Florida Blue enhances cancer care for thousands of members

TOI Stock  USD 0.21  0.02  10.53%   
Under 52% of Oncology Institute's investor base is interested to short. The analysis of overall sentiment of trading Oncology Institute stock suggests that many investors are impartial at this time. Oncology Institute's investing sentiment shows overall attitude of investors towards Oncology Institute.
  
New program aims to improve patient outcomes, experience, and quality of life by streamlining access to affordable and high-quality oncology care JACKSONVILLE

Read at gurufocus.com
Gurufocus Stories at Macroaxis
  

Oncology Institute Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Oncology Institute can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Oncology Institute Fundamental Analysis

We analyze Oncology Institute's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oncology Institute using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oncology Institute based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Institutions

Shares Owned By Institutions Comparative Analysis

Oncology Institute is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Oncology Institute Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oncology Institute stock to make a market-neutral strategy. Peer analysis of Oncology Institute could also be used in its relative valuation, which is a method of valuing Oncology Institute by comparing valuation metrics with similar companies.

Peers

Oncology Institute Related Equities

SGRYSurgery Partners   8.21   
0%
100.0%
AGLAgilon Health   4.79   
0%
58.0%
SEMSelect Medical   4.38   
0%
53.0%
LFSTLifestance Health   3.40   
0%
41.0%
AMSAmerican Shared   3.11   
0%
37.0%
BKDBrookdale Senior   2.60   
0%
31.0%
SNDASonida Senior   2.55   
0%
31.0%
UHSUniversal Health   2.45   
0%
29.0%
ADUSAddus HomeCare   1.39   
0%
16.0%
CCMConcord Medical   0.91   
0%
11.0%
EHCEncompass Health   0.66   
0%
8.0%
PNTGPennant   0.29   
0%
3.0%
MFCSFMedical Facilities   0.09   
1.0%
0%
JYNTJoint Corp   0.19   
2.0%
0%
ENSGEnsign   0.39   
4.0%
0%
MDMednax   1.12   
13.0%
0%
FSNUYFresenius   1.81   
22.0%
0%
RMYHYRamsay Health   3.17   
38.0%
0%

Complementary Tools for Oncology Stock analysis

When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities